Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-000854

CHIEF EXECUTIVE OFFICER sold 10,107 shares at $27.15 ($274,393)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Sale : show line 1 in the form 10b5-1 −10,107 $27.15 $274,393 168,155 D
Open-market sales · 10,107 sh · avg $27.15 · $274,393
Loading xslF345X05/form4-01092024_090130.xml…